Johnson & Johnson Hit With $29.4 Million Verdict

A California jury awarded $29.4 million to a woman and her spouse who alleged that her use of Johnson & Johnson’s talcum powder caused her mesothelioma. The $29.4 million was for compensatory damages. Johnson& Johnson plans to appeal this decision. No punitive damages were awarded.

There are about 14,000 cases across the country in which individuals are claiming J&J’s talc products have caused their cancer. In some cases, plaintiffs are arguing that there is asbestos in the talc and that J&J knew about the contamination for decades. In many of these cases, women are claiming that using J&J’s talcum powder in their genital areas caused their ovarian cancer.

GoldenbergLaw is investigating claims in which an individual was diagnosed with ovarian cancer or mesothelioma after extensive talcum powder use. Call us or fill out the contact form below. We deliver the Gold standard advocacy you deserve.

Recall Timeline for “Sartan” Drugs

Since July 2018, the FDA has issued several recalls for valsartan, irbesartan, and losartan. This timeline outlines the recalls as well as FDA updates pertaining to valsartan, irbesartan, and losartan. If you or a loved one developed liver cancer, stomach/intestinal cancer, colorectal cancer, kidney cancer, or pancreatic cancer after taking valsartan, losartan, or irbesartan, please fill out the contact form below.

The recall timeline for angiotension II receptor blockers

NDMA & NDEA: What’s the Difference?

In July 2018, the FDA recalled certain batches of valsartan after investigators found N-Nitrosimethylamine (NDMA) had contaminated the drug. Since then, several batches of valsartan, irbesartan, and losartan have been recalled due to NDMA and N-Nitrosodiethylamine (NDEA) contamination. These nitrosamines are classified as probable human carcinogens.

How Are They Similar?

NDMA and NDEA are both classified by the Environmental Protection Agency as probable human carcinogens. Exposure to these carcinogens can cause tumors to develop in the respiratory tract. Specifically, an individual may develop liver, kidney, stomach, colorectal, intestinal, and/or pancreatic cancer.

What’s the Difference?

The main difference between NDMA and NDEA is toxicity. NDEA happens to be about three times more toxic than NDMA.

What Should I Do?

If you or a loved one took a recalled valsartan, irbesartan, or losartan and developed liver, kidney, pancreatic, stomach, colorectal, or intestinal cancer, please fill out the form below. We deliver the Gold standard advocacy you deserve.